Bottom line
Is HTEC a good fund? The bottom line
HTEC is a managed technology sector ETF from Innovator.
Its expense ratio is 0.68% — about $68 a year on every $10,000 invested, cheaper than 57% of technology sector funds we track.
It returned +24.0% over one year, −3.9% a year over five years (as of Dec 31, 2025, per its prospectus).
With $69.1 million in net assets and 63 holdings, its largest position is Caredx, Inc. (2.7%) and the top 10 make up 22.1% of the portfolio.
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What HTEC invests in
The ROBO Global Healthcare Technology and Innovation ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the ROBO Global Healthcare Technology and Innovation Index (the Index).
The Fund normally invests in securities comprising the Index and in depositary receipts representing securities comprising the Index. The Index, which is owned and provided by ROBO Global Index LLC, a wholly owned subsidiary of VettaFi LLC (the Index Provider), is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology as described below and the potential to grow within this space through innovation and/or market adoption of their products and services (Healthcare Technology Companies). Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in securities of Healthcare Technology Companies. Index components are selected from a proprietary database of Healthcare Technology Companies that are organized into the…
From the fund's prospectus (filed Aug 27, 2026).
HTEC performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| HTEC | +24.0% | −3.9% | — |
| Technology Sector median | +24.0% | +10.0% | +16.7% |
Source: Fund prospectus, as of Dec 31, 2025
What HTEC costs
On a $10,000 investment, HTEC's 0.68% expense ratio costs about $68 a year. The prospectus estimates $979 in total costs over 10 years (assuming 5% annual returns). The median technology sector fund charges 0.75%.
HTEC top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Caredx, Inc. | 2.68% |
| 2 | Guardant Health, Inc. | 2.31% |
| 3 | Natera, Inc. | 2.23% |
| 4 | Twist Bioscience Corp | 2.23% |
| 5 | Thermo Fisher Scientific Incorporated | 2.18% |
| 6 | Medpace Holdings, Inc. | 2.12% |
| 7 | Adaptive Biotechnologies Corporation | 2.11% |
| 8 | Iqvia Holdings Inc | 2.10% |
| 9 | Illumina, Inc. | 2.09% |
| 10 | Arrowhead Pharmaceuticals, Inc. | 2.08% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 22.1% of the fund. See all top 25 holdings and asset mix →